Broadly neutralizing antibodies against COVID-19

The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an effective treatment. Since SARS-CoV-2 emerged, a variety of strains have acquired increasing numbers of mutations to gain increased t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Daming, Ren, Jingshan, Fry, Elizabeth E, Stuart, David I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301462/
https://www.ncbi.nlm.nih.gov/pubmed/37285620
http://dx.doi.org/10.1016/j.coviro.2023.101332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301462/
https://www.ncbi.nlm.nih.gov/pubmed/37285620
http://dx.doi.org/10.1016/j.coviro.2023.101332

Ejemplares similares